Modulation of MRTF-A activity in pathologic fibrosis and wound healing
Abstract:
The present disclosure concerns uses for isoxazole compounds or salts or analogs thereof for the treatment of wounds. The present disclosure also concerns devices for delivering a isoxazole compound or salts or an analogs thereof to a wound site.
Information query
Patent Agency Ranking
0/0